Dr. Xu Hui – O&G CUHK

1

Immunosuppression and immunotherapy in endometriosis: review of pathophysiology, recent development and future perspectives He Y, Hung KSW, Xu H, Wang CC In: Immunology of Endometriosis: Pathogenesis and Management

2

Receptor tyrosine kinase inhibitor Sunitinib as novel immunotherapy to inhibit myeloid-derived suppressor cells for treatment of endometriosis He Y, Hung SW, Liang B, Zhang RZ, Gao YT, Chu CY, Xu H, Zhang T, Chung JPW, Wang CC Front. Immunol. 2021 July;12:641206

3

Effects of high progesterone in in-vitro fertilization cycle on DNA methylation and gene expression of adhesion molecules on endometrium during implantation window Xiong Y, Hu L, Zhang T, Wang M, Xu H, Li TC, Sun Y, Wang CC J Assist Reprod Genet. 2020 Jan;37(1):33-43

4

Prodrug of green tea epigallocatchin-3-gallate (Pro-EGCG) as a potent anti-angiogenesis agent for endometriosis in mice. Wang CC, Xu H, Man GCW, Zhang T, Chu KO, Chu CY, Cheng JT, Li G, He YX, Qin L, Lau TS, Kwong J, Chan TH. Angiogenesis 2013 Aug; 16(1): 59-69.

5

Vascular endothelial growth factor C is increased in endometrium and promotes endothelial functions, vascular permeability and angiogenesis and growth of endometriosis. Xu H, Zhang T, Man GCW, May KE, Becker CM, Davis TN, Kung AL, Birsner AE, D’Amato RJ, Wong AW, Wang CC. Angiogenesis 2013 Jul; 16: 541-551.

6

Anti-angiogenic effects of green tea catechin on an experimental endometriosis mouse model. Xu H, Lui WT, Chu NCY, Ng PS, Wang CC, Rogers MS Hum Reprod 2009;24(3): 608 - 618